• Principais características
  • Proporciona barreira antimicrobiana.
  • Previne a infecção.
  • Elimina mais de 150 agentes patogénicos.
  • Não adere ao leito da ferida.
  • Ajuda na cicatrização, protegendo a ferida da contaminação bacteriana.
  • Libertação sustentada da prata.
  • Apresentação e códigos
Código
produto
CNP Descrição Unidades
Caixa
Unidade
mínima
venda
66800396 - 5 x 5 cm 5u 5u
66800398 6165423 10 x 10 cm 5u 5u
66800399 - 10 x 10 cm 12u 12u
66800409 6165431 10 x 20 cm 12u 12u
66800419 6165449 20 x 40 cm 6u 6u
66800432 6165456 40 x 40 cm 6u 6u
66800435 - 10 x 120 cm 6u 6u

Partilhar no Facebook Partilhar no Twitter Partilhar por email Mais opções

  • Utilização do ACTICOAT* FLEX e ALLEVYN* GENTLE BORDER no tratamento de uma deiscência na zona dorsal.

  • ACTICOAT* FLEX, um novo avanço no tratamento de uma paciente com uma úlcera venosa recidivante com camada de biofilme bacteriano.

Bibliografia

1. Burrell et al, ‘Efficacy of Silver-Coated Dressings as Bacterial Barriers in a Rodent Burn Sepsis Model’, WOUNDS 1999; 11(4):64-71. 

2. Walton, G; Wound Healing Study Summary Report.

3. Daubney, L; Demand Absorbency of Acticoat Flex 3, ACTICOAT Flex 7 ACTICOAT and Silverlon, report reference DS.08.153.R2.

4. Demonstrable.

5. Driffield, K; Antimicrobial Activity of ACTICOAT Flex 3 against a Broad Spectrum of Wound Pathogens, Data on File reference 0810016.

6. Driffield, K; Antimicrobial Activity of ACTICOAT Flex 3 dressings in a 3 day Repeat Challenge Test, Data on File reference 0810017.

7. Wright et al, ‘Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment’, American Journal of Infection Control 1998; 26(6):572-577.

8. Wright et al, ‘Efficacy of topical silver against fungal burn wound pathogens’, American Journal of Infection Control 1999; 27(4):344-350.

9. Tredget et al, ‘A Matched-Pair, Randomised Study Evaluating the Efficacy and Safety of Acticoat silver-Coated Dressings for the Treatment of Burn Wounds’, Journal of Burn Care & Rehabilitation 1998; 19(6):531 - 537.

10. Stephens R, Silverstein P, Meites H, Jett M, Brou J. An Evaluation of Acticoat Dressings with Regard to Cost and Control of Infection.

11. Daubney, L; Silver Release Testing of ACTICOAT Flex 3 Dressings. Report reference DS/08/078/R2.

12. Sibbald R G, Browne A C, Coutts P, Queen D, ‘A Screening Evaluation of an Ionized Nanocrystalline Silver Dressing in Chronic Wound Care’. Ostomy Wound Management 2001; 47(10): 38-4.

13. Myers, D; Acticoat Dressing: Wound Bed Preparation and Wound Trauma

14. Walton, G; Nonclinical Overview of ACTICOAT Flex 3.

15. Driffield, K; ACTICOAT Flex prevents the formation of biofilms, Data on File reference 0812024.

16. Driffield, K; Antimicrobial activity of ACTICOAT Flex 3 against pathogenic wound pathogens, Data on File reference 0812023.

17. Smith et al; A 7 patient single centre, open label study to assess systemic Silver Levels before, during and after treatment of high total body surface area graft sites and partial thickness wounds with Acticoat and Acticoat Absorbent, report reference CT05/01.

18. Daubney, L; Acticoat Flex 7 - Evaluation of Extensibility, report reference DS.08.123.R1

19. Lumb, H; The Antimicrobial Activity of Acticoat and Acticoat Flex 3 while Under Negative Pressure, Data on File reference 0810010.

20. Bannister, N; NPWT Summary.

21. Driffield, K; ACTICOAT Flex 3 has antimicrobial activity in 30 minutes, Data on File reference 0810018.

22. Myers, D; The Clinical and Physical Properties of Acticoat dressing and the Moist Wound Environment.

23. Singer A J et al; Persistent wound infection delays epidermal maturation and increases scarring in thermal burns; Wound Repair and Regeneration Vol 10. No. 6 372 - 377.

24. Ovington L G; Update on Today’s Tissue Healing Technologies. Ir a link na web.

25. Bowler P G; Wound pathophysiology, infection and therapeutic options, Ann Med 2002; 34: 419 - 427.

26. Walker M, Bowler P G, Phil M, Cochrane C A; In Vitro Studies to show Sequestration of Matrix Metalloproteinases by Silver-Containing Wound Care Products, Ostomy Wound Management Vol 53, issue 9 18 - 25.

27. Thomas S, Treating Malodorous Wounds. Community Look, October 1987 27 - 30.

28. Driffield, K; Antimicrobial activity testing of ACTICOAT Flex 7 dressings against a broad spectrum of wound pathogens using log reduction, report reference WRP-TW141-022.

29. Carpenter, S; Investigation into wound bed pressure under ACTICOAT using an in-vitro model, report reference DS/09/019/R1.

Esta página está dirigida exclusivamente para profissionais de saúde. O conteúdo e informação deste WebSite foi redigido por profissionais de saúde devidamente qualificados, no entanto esta informação não constitui aconselhamento médico, mas um serviço com caracter informativo. O uso indevido de qualquer dos produtos aqui anunciados pode causar a deterioração da saúde se não for utilizado de acordo com as indicações para utilização do produto. A Smith&Nephew não recomenda nem promove a utilização indevida de qualquer produto.